Prior guidance was $1.03B-$1.095B. Consensus $1.06B.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ACAD:
- Acadia Pharmaceuticals reports Q2 EPS 16c, consensus 14c
- ACAD Earnings this Week: How Will it Perform?
- Cautious Outlook on ACADIA Pharmaceuticals Amid Market Penetration and Growth Uncertainties
- Taysha Gene Therapies initiated with a Buy at BofA
- Acadia Pharmaceuticals price target raised to $22 from $19 at Oppenheimer